Publisher
Springer Nature Singapore
Reference7 articles.
1. Kubo K, Wan X. On drug-induced lung damage. Prog Jap Med. 2007;28(3):98–9.
2. Sun X, Zhu Y, Feng Y, et al. Analysis of anti-tumor targeted drugs induced lung disease. Chin Pharm J. 2018;53(16):1425–30.
3. Wang Q, Wu X. Clinical manifestations and treatment of immune-related adverse reactions in the therapy by immune checkpoint inhibitors. Chin J Immunol. 2017;33(4):615–20.
4. Tirumani SH, Ramaiya NH, Keraliya A, et al. Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res. 2015;3(10):1185–92.
5. Ramos-Casals M, Perez-Alvarez R, Perez-de-Lis M, et al. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases. Am J Med. 2011;124(5):386–94.